Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Five Prime Therapeutics Inc (NASDAQ:FPRX)

28.06
Delayed Data
As of Aug 18
 -0.44 / -1.54%
Today’s Change
25.97
Today|||52-Week Range
60.98
-44.00%
Year-to-Date
No recent news for Five Prime Therapeutics Inc.

Today’s Trading

Previous close28.50
Today’s open28.17
Day’s range27.17 - 29.04
Volume333,976
Average volume (3 months)287,510
Market cap$811.0M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-126.44%
Earnings growth (this year)-117.62%
Earnings growth (next 5 years)--
Revenue growth (last year)-91.92%
P/E ratioNM
Price/Sales44.01
Price/Book1.97

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-0.05-0.35%
MYOVMyovant Sciences Ltd+1.61+13.96%
SGMOSangamo Therapeutics...-0.35-3.41%
CRSPCRISPR Therapeutics ...-0.08-0.43%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 14, 2017
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$30.7M
Annual profit (last year)-$65.7M
Net profit margin-214.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Lewis T. Williams
Chief Operating Officer &
Director
Aron M. Knickerbocker
Corporate headquarters
South San Francisco, California

Forecasts